Skip to main content

FDA stalled on CBD for now: Analyst

FDA expresses interest in more studies of CBD but no real action is expected without a push from Congress, according to Cowen analyst.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.